Cargando…

A person-centred intervention remotely targeting family caregivers’ support needs in the context of allogeneic hematopoietic stem cell transplantation—a feasibility study

PURPOSE: Allogeneic hematopoietic stem cell transplantation (HSCT) is an intensive curative treatment that increases family caregivers’ burden. The aim of this study was to explore the feasibility of remotely assessing and addressing family caregivers’ support needs in terms of demand and acceptabil...

Descripción completa

Detalles Bibliográficos
Autores principales: Kisch, Annika M., Bergkvist, Karin, Adalsteinsdóttir, Sólveig, Wendt, Christel, Alvariza, Anette, Winterling, Jeanette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366782/
https://www.ncbi.nlm.nih.gov/pubmed/35951098
http://dx.doi.org/10.1007/s00520-022-07306-w
_version_ 1784765643306827776
author Kisch, Annika M.
Bergkvist, Karin
Adalsteinsdóttir, Sólveig
Wendt, Christel
Alvariza, Anette
Winterling, Jeanette
author_facet Kisch, Annika M.
Bergkvist, Karin
Adalsteinsdóttir, Sólveig
Wendt, Christel
Alvariza, Anette
Winterling, Jeanette
author_sort Kisch, Annika M.
collection PubMed
description PURPOSE: Allogeneic hematopoietic stem cell transplantation (HSCT) is an intensive curative treatment that increases family caregivers’ burden. The aim of this study was to explore the feasibility of remotely assessing and addressing family caregivers’ support needs in terms of demand and acceptability using the Carer Support Needs Assessment Tool Intervention (CSNAT-I) in the HSCT context. METHODS: CSNAT-I consists of an evidence-based tool and a five-stage person-centred process. The intervention was performed remotely by two designated nurses from two HSCT centres, one before HSCT and the second 6 weeks after (November 2020 to March 2021). To capture the experiences of using CSNAT-I, interviews were conducted with family caregivers and reflections were gathered from the designated nurses. RESULTS: Of 34 eligible family caregivers, 27 participated, 70% were partners and the rest children, siblings or other relatives. The main support needs were knowing what to expect in the future and dealing with your feelings and worries. The most frequent support actions according to CSNAT-I were psychological support and medical information. Four categories summarised family caregivers and designated nurses’ experiences: CSNAT-I was relevant and became an eye opener; nurses’ experiences were important for enabling trustful CSNAT-I conversations; CSNAT-I provided family caregivers with support and a sense of security; and CSNAT-I gave family caregivers insight and enabled change. CONCLUSION: Both family caregivers and designated nurses experienced that using CSNAT-I in an HSCT context was feasible and had the potential to provide valuable support for most of the participating family caregivers.
format Online
Article
Text
id pubmed-9366782
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-93667822022-08-11 A person-centred intervention remotely targeting family caregivers’ support needs in the context of allogeneic hematopoietic stem cell transplantation—a feasibility study Kisch, Annika M. Bergkvist, Karin Adalsteinsdóttir, Sólveig Wendt, Christel Alvariza, Anette Winterling, Jeanette Support Care Cancer Original Article PURPOSE: Allogeneic hematopoietic stem cell transplantation (HSCT) is an intensive curative treatment that increases family caregivers’ burden. The aim of this study was to explore the feasibility of remotely assessing and addressing family caregivers’ support needs in terms of demand and acceptability using the Carer Support Needs Assessment Tool Intervention (CSNAT-I) in the HSCT context. METHODS: CSNAT-I consists of an evidence-based tool and a five-stage person-centred process. The intervention was performed remotely by two designated nurses from two HSCT centres, one before HSCT and the second 6 weeks after (November 2020 to March 2021). To capture the experiences of using CSNAT-I, interviews were conducted with family caregivers and reflections were gathered from the designated nurses. RESULTS: Of 34 eligible family caregivers, 27 participated, 70% were partners and the rest children, siblings or other relatives. The main support needs were knowing what to expect in the future and dealing with your feelings and worries. The most frequent support actions according to CSNAT-I were psychological support and medical information. Four categories summarised family caregivers and designated nurses’ experiences: CSNAT-I was relevant and became an eye opener; nurses’ experiences were important for enabling trustful CSNAT-I conversations; CSNAT-I provided family caregivers with support and a sense of security; and CSNAT-I gave family caregivers insight and enabled change. CONCLUSION: Both family caregivers and designated nurses experienced that using CSNAT-I in an HSCT context was feasible and had the potential to provide valuable support for most of the participating family caregivers. Springer Berlin Heidelberg 2022-08-11 2022 /pmc/articles/PMC9366782/ /pubmed/35951098 http://dx.doi.org/10.1007/s00520-022-07306-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Kisch, Annika M.
Bergkvist, Karin
Adalsteinsdóttir, Sólveig
Wendt, Christel
Alvariza, Anette
Winterling, Jeanette
A person-centred intervention remotely targeting family caregivers’ support needs in the context of allogeneic hematopoietic stem cell transplantation—a feasibility study
title A person-centred intervention remotely targeting family caregivers’ support needs in the context of allogeneic hematopoietic stem cell transplantation—a feasibility study
title_full A person-centred intervention remotely targeting family caregivers’ support needs in the context of allogeneic hematopoietic stem cell transplantation—a feasibility study
title_fullStr A person-centred intervention remotely targeting family caregivers’ support needs in the context of allogeneic hematopoietic stem cell transplantation—a feasibility study
title_full_unstemmed A person-centred intervention remotely targeting family caregivers’ support needs in the context of allogeneic hematopoietic stem cell transplantation—a feasibility study
title_short A person-centred intervention remotely targeting family caregivers’ support needs in the context of allogeneic hematopoietic stem cell transplantation—a feasibility study
title_sort person-centred intervention remotely targeting family caregivers’ support needs in the context of allogeneic hematopoietic stem cell transplantation—a feasibility study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366782/
https://www.ncbi.nlm.nih.gov/pubmed/35951098
http://dx.doi.org/10.1007/s00520-022-07306-w
work_keys_str_mv AT kischannikam apersoncentredinterventionremotelytargetingfamilycaregiverssupportneedsinthecontextofallogeneichematopoieticstemcelltransplantationafeasibilitystudy
AT bergkvistkarin apersoncentredinterventionremotelytargetingfamilycaregiverssupportneedsinthecontextofallogeneichematopoieticstemcelltransplantationafeasibilitystudy
AT adalsteinsdottirsolveig apersoncentredinterventionremotelytargetingfamilycaregiverssupportneedsinthecontextofallogeneichematopoieticstemcelltransplantationafeasibilitystudy
AT wendtchristel apersoncentredinterventionremotelytargetingfamilycaregiverssupportneedsinthecontextofallogeneichematopoieticstemcelltransplantationafeasibilitystudy
AT alvarizaanette apersoncentredinterventionremotelytargetingfamilycaregiverssupportneedsinthecontextofallogeneichematopoieticstemcelltransplantationafeasibilitystudy
AT winterlingjeanette apersoncentredinterventionremotelytargetingfamilycaregiverssupportneedsinthecontextofallogeneichematopoieticstemcelltransplantationafeasibilitystudy
AT kischannikam personcentredinterventionremotelytargetingfamilycaregiverssupportneedsinthecontextofallogeneichematopoieticstemcelltransplantationafeasibilitystudy
AT bergkvistkarin personcentredinterventionremotelytargetingfamilycaregiverssupportneedsinthecontextofallogeneichematopoieticstemcelltransplantationafeasibilitystudy
AT adalsteinsdottirsolveig personcentredinterventionremotelytargetingfamilycaregiverssupportneedsinthecontextofallogeneichematopoieticstemcelltransplantationafeasibilitystudy
AT wendtchristel personcentredinterventionremotelytargetingfamilycaregiverssupportneedsinthecontextofallogeneichematopoieticstemcelltransplantationafeasibilitystudy
AT alvarizaanette personcentredinterventionremotelytargetingfamilycaregiverssupportneedsinthecontextofallogeneichematopoieticstemcelltransplantationafeasibilitystudy
AT winterlingjeanette personcentredinterventionremotelytargetingfamilycaregiverssupportneedsinthecontextofallogeneichematopoieticstemcelltransplantationafeasibilitystudy